Jeffrey V. Poulton, EVP, Chief Financial Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 1,763 shares at $194.94 ($343K) on 2023-04-27, disclosed to the SEC on 2023-04-28.
Open-market sale of $343k ALNY by EVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $193.18 | 81 | $16K | 4.6% |
| 2 | $193.93 | 372 | $72K | 21.0% |
| 3 | $193.93 | 372 | $72K | 21.0% |
| 4 | $194.94 | 414 | $81K | 23.5% |
| 5 | $194.94 | 414 | $81K | 23.5% |
| 6 | $195.65 | 42 |
| $8K |
| 2.4% |
| 7 | $197.08 | 68 | $13K | 3.9% |
| Total | $194.53 avg | 1,763 | $343K | 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $695K | — | Filing → |
| ALNY | SELL | 2026-01-14 | $1.0M | — | Filing → |
| ALNY | SELL | 2025-10-03 | $3.4M | — | Filing → |